Clinical trial / 2014
Ginger supplementation reduced antiretroviral-induced nausea and vomiting in HIV-positive patients.
In a double-blind trial, 102 HIV-positive patients were randomized to receive either 500 mg ginger or placebo twice daily 30 minutes before each antiretroviral dose for 14 days. During the first 2 weeks, nausea was experienced by 56.4% (29 patients) in the ginger group versus 90.2% (46 patients) in the placebo group (p = 0.001). Additionally, 9.8% (5 patients) in the ginger group versus 47.1% (24 patients) in the placebo group reported at least one episode of vomiting (p = 0.01).
- Study type
- Double-blind randomized controlled trial
- Who was studied
- 102 HIV-positive patients attending the HIV clinic of Imam Khomeini Hospital
- What was measured
- Severity of nausea and number of vomiting episodes
THE PAPER
Ginger for prevention of antiretroviral-induced nausea and vomiting: a randomized clinical trial.
Dabaghzadeh F, Khalili H, Dashti-Khavidaki S, Abbasian L, Moeinifard A. Expert Opin Drug Saf, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.